S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. - Matthew J. Frank; John Baird; Anne Kramer; Shabnum Patel; Bita Sahaf; Juliana Craig; Emma Crawford; Sheren Younes; Jean Oak; Yasodha Natkunan; Jay Spiegel; Zachary Ehlinger; et al. (HemaSphere, 2023)